We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oilex Ld | LSE:OEX | London | Ordinary Share | AU000000OEX8 | ORD NPV |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.165 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMOEX
RNS Number : 6227U
Oilex Ltd
01 April 2019
ASX Announcement
1 April 2019
ASX: OEX
AIM: OEX
Issue of Shares and Section 708A(5)(e) Notice
Oilex Ltd (the Company) advises that it has issued 4,532,864 new ordinary shares as consideration in lieu of Non-Executive Directors' fees and fees payable to consultants.
These new ordinary shares were issued at a price of AUD $0.005 per ordinary share.
Hot Features
Premium
Shares Issued
--------------------------- ---------------------------
Mr B Lingo 2,228,400
Mr P Haywood 544,464
Consultants 1,760,000
---------------------------
4,532,864
The issue of shares to Non-Executive Directors in lieu of fees was approved by shareholders on 29 November 2018. The shares issued to consultants is made under the Company's Listing Rule 7.1 capacity.
Oilex gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Act) that:
1. Oilex issued the Shares without disclosure to investors under Part 6D.2 of the Act;
2. as at the date of this notice, Oilex has complied with: (a) the provisions of Chapter 2M of the Act as they apply to Oilex; and (b) section 674 of the Act; and
3. as at the date of this notice, there is no information that is 'excluded information' within the meaning of sections 708A(7) and 708A(8) of the Act.
Admission of 4,532,864 shares is expected to become effective and dealings to commence at 8.00 a.m. on 4 April 2019. Following Admission of these shares, the Company will have 2,581,520,863 shares on issue. The Company does not currently hold any shares in treasury. Accordingly, the total number of voting rights will be 2,581,520,863. In addition, please find attached the applicable ASX Appendix 3B.
For and on behalf of Oilex Ltd
Mark Bolton
Chief Financial Officer Company Secretary
For further information, please contact:
Investor AIM Broker AIM Nominated Media Enquires Media Enquiries
Enquiries Cornhill Capital Adviser (UK) (Aus)
Oilex Ltd Limited Strand Hanson Vigo Citadel-MAGNUS
Joe Salomon Broker Limited Communications Michael Weir
Managing Daniel Gee Nominated Adviser Public Relations Email:
Director Email: Rory Murphy/Ritchie Patrick mweir@citadelmagnus.
Email: danielg@cornhillcapital. Balmer d'Ancona/Chris com
oilex@oilex. com Email: McMahon Tel: +618
com.au Tel: +44 20 oilex@strandhanson. Email: 6160 4900
Tel: +61 3700 2500 co.uk patrick.dancona@vi Australia
8 9485 3200 UK Tel: +44 20 gocomms.com
Australia 7409 3494 chris.mcmahon@vigo
UK comms.com
Tel:+ 44 20 7390
0230
UK
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity OILEX LTD ABN 50 078 652 632
We (the entity) give ASX the following information.
Part 1 -- All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities Fully Paid Ordinary
issued or to be issued Shares
2 Number of +securities a) 2,772,864 shares
issued or to be issued in lieu of directors'
(if known) or maximum fees
number which may be issued b) 1,760,000 shares
as consideration for
consulting services
3 Principal terms of the Fully Paid Ordinary
+securities (eg, if options, Shares
exercise price and expiry
date; if partly paid +securities,
the amount outstanding
and due dates for payment;
if +convertible securities,
the conversion price and
dates for conversion)
4 Do the (+) securities rank Yes
equally in all respects
from the date of allotment
with an existing +class
of quoted +securities?
If the additional securities
do not rank equally, please
state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
5 Issue price or consideration a) $0.005 per share
b) $0.005 per share
--------------------------------------
6 Purpose of the issue a) 2,772,864 shares in lieu of
(If issued as consideration directors' fees
for the acquisition of b) 1,760,000 shares as consideration
assets, clearly identify for consulting services
those assets)
--------------------------------------
6a Is the entity an (+) eligible
entity that has obtained Yes
security holder approval
under rule 7.1A?
If Yes, complete sections
6b - 6h in relation to
the +securities the subject
of this Appendix 3B, and
comply with section 6i
--------------------------------------
6b The date the security holder
resolution under rule 7.1A 29 November 2018
was passed
--------------------------------------
6c Number of (+) securities
issued without security Nil
holder approval under rule
7.1
--------------------------------------
6d Number of (+) securities
issued with security holder Not applicable
approval under rule 7.1A
--------------------------------------
6e Number of +securities issued Not applicable
with security holder approval
under rule 7.3, or another
specific security holder
approval (specify date
of meeting)
--------------------------------------
6f Number of (+) securities Not applicable
issued under an exception
in rule 7.2
--------------------------------------
6g If (+) securities issued Not applicable
under rule 7.1A was issue
price at least 75% of 15
day VWAP as calculated
under rule 7.1A.3? Include
the (+) issue date and
both values. Include the
source of the VWAP calculation.
--------------------------------------
6h If (+) securities were issued Not applicable
under rule 7.1A for non-cash
consideration, state date
on which valuation of
consideration
was released to ASX Market
Announcements
6i Calculate the entity's remaining Listing Rule 7.1: 137,409,930
issue capacity under rule 7.1 Listing Rule 7.1A: 237,008,474
and rule 7.1A - complete Annexure
1 and release to ASX Market
Announcements
7 (+) Issue dates 1 April 2019
Notes: The issue date may be
prescribed by ASX (refer to
the definition of issue date
in rule 19.12). For example,
the issue date for a pro rata
entitlement issue must comply
with the applicable timetable
in appendix 7A.
Cross reference: item 33 of
Appendix 3B.
---------------------------------------------------------------------------------
8 Number and +class of all +securities Number (+) Class
quoted on ASX (including the
(+) securities in section 2
if applicable)
---------------------------------
2,581,520,863 Fully Paid Ordinary
Shares
--------------------------------- ----------------------------------------------
9 Number and +class of all +securities Number +Class
not quoted on ASX (including
the securities in section 2
if applicable)
---------------------------------
91,666,666 Options
60,664,887 ($0.0034, 26/07/2019)
2,222,222 Options
6,666,667 ($0.004121, 1/10/2019)
Options
(GBP0.00225, 22/05/2020)
Options
(GBP0.0036, 24/12/2020)
--------------------------------- ----------------------------------------------
10 Dividend policy (in the case Not applicable
of a trust, distribution policy)
on the increased capital (interests)
---------------------------------------------------------------------------------
Part 2 -- Pro rata issue
11 Is security holder approval Not applicable
required?
12 Is the issue renounceable
or non-renounceable?
13 Ratio in which the +securities
will be offered
14 +Class of +securities
to which the offer relates
15 +Record date to determine
entitlements
16 Will holdings on different
registers (or subregisters)
be aggregated for calculating
entitlements?
17 Policy for deciding entitlements
in relation to fractions
18 Names of countries in
which the entity has
security holders who
will not be sent new
issue documents
Note: Security holders
must be told how their
entitlements are to be
dealt with.
Cross reference: rule
7.7.
19 Closing date for receipt
of acceptances or renunciations
20 Names of any underwriters
21 Amount of any underwriting
fee or commission
22 Names of any brokers
to the issue
23 Fee or commission payable
to the broker to the
issue
24 Amount of any handling
fee payable to brokers
who lodge acceptances or
renunciations on behalf
of security holders
25 If the issue is contingent
on security holders' approval,
the date of the meeting
26 Date entitlement and acceptance
form and offer documents
will be sent to persons
entitled
27 If the entity has issued
options, and the terms
entitle option holders
to participate on exercise,
the date on which notices
will be sent to option
holders
28 Date rights trading will
begin (if applicable)
29 Date rights trading will
end (if applicable)
30 How do security holders
sell their entitlements
in full through a broker?
31 How do security holders
sell part of their entitlements
through a broker and accept
for the balance?
32 How do security holders
dispose of their entitlements
(except by sale through
a broker)?
33 +Issue date
Part 3 -- Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of securities
(tick one)
(a) ü (+) Securities described in Part 1
(b) o All other (+) securities
Example: restricted securities at the end of the
escrowed period, partly paid securities that become
fully paid, employee incentive share securities
when restriction ends, securities issued on expiry
or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or
documents
35 If the +securities are +equity securities, the names
of the 20 largest holders of the additional +securities,
and the number and percentage of additional +securities
held by those holders
36 If the +securities are +equity securities, a distribution
schedule of the additional +securities setting out
the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
-----------------
38 Number of securities for which Not applicable
+quotation is sought
39 +Class of +securities for which
quotation is sought
-------------------
40 Do the +securities rank equally
in all respects from the +issue
date with an existing +class
of quoted +securities?
If the additional +securities
do not rank equally, please
state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
-------------------
41 Reason for request for quotation
now
Example: In the case of restricted
securities, end of restriction
period
(if issued upon conversion of
another (+) security, clearly
identify that other (+) security)
-------------------
42 Number and +class of all +securities Number (+) Class
quoted on ASX (including the
securities in clause 38)
-------
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
-- The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
-- There is no reason why those +securities should not be granted +quotation.
-- An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
-- If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Mark Bolton
Company Secretary
Date: 1 April 2019
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for (+) eligible entities
Introduced 01/08/12, Amended 04/03/13
Part 1
Rule 7.1 - Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
Insert number of fully paid 1,874,197,579 shares
(+) ordinary securities on
issue 12 months before the
(+) issue date or date of
agreement to issue
------------------------------------------------------
Add the following: 90,190,999 shares (Issued 16/11/18)
* Number of fully paid (+) ordinary securities issued 10,000,000 shares (Issued 5/12/18)
in that 12 month period under an exception in rule
7.2
------------------------------------------------------
2,770,800 shares (issued 15/05/2018)*
* Number of fully paid (+) ordinary securities issued 125,000,000 shares (Issued 15/05/2018)
in that 12 month period with shareholder approval 157,894,737 shares (Issued 17/09/2018)
10,843,344 shares (Issued 26/09/2018)
91,222,451 shares (Issued 26/09/2018)
3,467,070 shares (Issued 26/09/2018)*
1,724,904 shares (Issued 29/11/2018)*
2,772,864 shares (Issued 01/04/2019)^
* approved by shareholders on
29/11/2017
^ approved by shareholders on
29/11/2018
------------------------------------------------------
Nil
* Number of partly paid (+) ordinary securities that
became fully paid in that 12 month period
------------------------------------------------------
Note:
* Include only ordinary securities here - other classes
of equity securities cannot be added
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
------------------------------------------------------
Subtract the number of fully Nil
paid (+) ordinary securities
cancelled during that 12
month period
------------------------------------------------------
"A" 2,370,084,748
------------------------------------------------------
Step 2: Calculate 15% of "A"
"B" 0.15
[Note: this value cannot be
changed]
-------------------------------------------
Multiply "A" by 0.15 355,512,712
-------------------------------------------
Step 3: Calculate "C", the amount of placement capacity
under rule 7.1 that has already been used
Insert number of (+) equity 29,120,559 shares (Issued
securities issued or agreed 14/12/2018)
to be issued in that 12 71,527,778 shares (Issued
month period not counting 21/12/2018)
those issued: 4,291,667 shares (Issued
* Under an exception in rule 7.2 21/12/2018)
39,583,333 shares (Issued
21/12/2018)
* Under rule 7.1A 2,375,000 shares (Issued
21/12/2018)
55,555,556 shares (Issued
* With security holder approval under rule 7.1 or rule 21/12/2018)
7.4 13,888,889 shares (Issued
20/01/2019)
1,760,000 shares (Issued
Note: 01/04/2019)
* This applies to equity securities, unless
specifically excluded - not just ordinary securities
* Include here (if applicable ) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
-------------------------------------------
"C" 218,102,782
-------------------------------------------
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining
placement capacity under rule 7.1
"A" x 0.15
Note: number must be same
as shown in Step 2 355,512,712
-------------------------------------------
Subtract "C"
Note: number must be same
as shown in Step 3 218,102,782
-------------------------------------------
Total ["A" x 0.15] - "C" 137,409,930
[Note: this is the remaining
placement
capacity under rule 7.1]
-------------------------------------------
Part 2
Rule 7.1A - Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
"A"
Note: number must be same
as shown in Step 1 of Part
1 2,370,084,748
------------------------------------------
Step 2: Calculate 10% of "A"
"D" 0.10
Note: this value cannot
be changed
------------------------------------------
Multiply "A" by 0.10 237,008,474
------------------------------------------
Step 3: Calculate "E", the amount of placement capacity under
rule 7.1A that has already been used
Insert number of equity securities Nil
issued or agreed to be issued
in that 12 month period under
rule 7.1A
Notes:
* This applies to equity securities - not just ordinary
securities
* Include here - if applicable - the securities the
subject of the Appendix 3B to which this form is
annexed
* Do not include equity securities issued under rule
7.1 (they must be dealt with in Part 1), or for which
specific security holder approval has been obtained
* It may be useful to set out issues of securities on
different dates as separate line items
------------------------------------------
"E" Nil
------------------------------------------
Step 4: Subtract "E" from ["A" x "D"] to calculate remaining
placement capacity under rule 7.1A
"A" x 0.10
Note: number must be same
as shown in Step 2 237,008,474
------------------------------------------
Subtract "E" Nil
Note: number must be same
as shown in Step 3
------------------------------------------
Total ["A" x 0.10] - "E" 237,008,474
Note: this is the remaining
placement
capacity under rule 7.1A
------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCLIFESSTILIIA
(END) Dow Jones Newswires
April 01, 2019 02:00 ET (06:00 GMT)
1 Year Oilex Ld Chart |
1 Month Oilex Ld Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
